Recent Transactions

1

Helperby Therapeutics

Undisclosed US Biotechnology

Company

Research CollaborationJune 2014

Q Chip Ltd

Undisclosed US Pharmaceutical

Company

Strategic AdvisoryApril 2014

4-Antibody AG*

Sale to Agenus Inc $40M+ with $10M

upfront

January 2014

Almac Group*

License of Chemotherapy Benefit Test to

Genomic Health Inc$9M + milestones

and royalties

November 2013

Selexis SA*

Sale of royalty portfolio to Ligand

Pharmaceuticals Inc

April 2013

Almac Discovery Ltd

Strategic Advisory2014

Undisclosed

Strategic AdvisoryJune 2014

*Transaction done prior to Longcross incorporation

Altacor Ltd

Sale to Esperante BVUndisclosed terms

Press release

Company saleJune 2014